Lung Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Lung Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 13, 2018

---

• A machine learning approach for somatic mutation discovery.  
  Wood Derrick E et al. Science translational medicine 2018 Sep 10(457)
• Are We Being Misled About Precision Medicine?  
  L Szabo, New York Times, September 11, 2018
• COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.  
  Li Jiaxi et al. Medicine 2018 Aug 97(35) e11859
• Future of Evidence Synthesis in Precision Oncology: Between Systematic Reviews and Biocuration  
  SM Boca et al, JCO Precision Oncology, September 2018
• Optimization of routine testing for MET exon 14 splice site mutations in non-small cell lung cancer patients.  
  Descarpentries Clotilde et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Sep
• Unraveling the Mystery of What Gives Exceptional Responders Their Superpower 
  J Cavallo, ASCO Post, August 2018
• [Study Progression on Non-small Cell Lung Cancer with EGFR Mutation ?Treated by Immune Checkpoint Inhibitors].  
  Bai Rilan et al. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2018 Aug 21(8) 641-648
• Broad Genomic Testing in NSCLC: No Survival Benefit?  
  et al. Cancer discovery 2018 Aug
• Early Epigenetic Markers for Precision Medicine.  
  Dumitrescu Ramona G et al. Methods in molecular biology (Clifton, N.J.) 2018 18563-17
• Epigenome-Based Precision Medicine in Lung Cancer.  
  Kim Dongho et al. Methods in molecular biology (Clifton, N.J.) 2018 185657-85